[A Case of Thoracic Esophageal Cancer Treated with COVID-19 Pneumonia during Preoperative Chemoradiotherapy(CRT)]

Gan To Kagaku Ryoho. 2023 Feb;50(2):267-269.
[Article in Japanese]

Abstract

Introduction: There is concerned that prognosis of cancer-bearing patients is adversely affected by postponement of cancer treatment due to infection with a new type of coronavirus(COVID-19). We report a case of thoracic esophageal cancer treated with COVID-19 pneumonia during preoperative CRT. A 60-year-old female diagnosed as having Stage Ⅳ thoracic esophageal cancer(cT3N0M1LYM[104R])started receiving preoperative chemoradiotherapy. On the 12th day, she had a fever and was diagnosed with COVID-19 infection. CRT temporarily interrupted and she was treated for COVID-19 pneumonia preferentially. CRT was resumed promptly after remission. Finally, video-Assisted radical esophagectomy was performed. There were no postoperative complications. Nivolumab was started as an adjuvant therapy on the 2nd postoperative months.

Conclusions: We experienced a case of thoracic esophageal cancer in which COVID-19 pneumonia was treated during preoperative CRT, and CRT and surgery were completed without complications by appropriate treatment.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • COVID-19*
  • Chemoradiotherapy
  • Combined Modality Therapy
  • Esophageal Neoplasms* / surgery
  • Esophagectomy
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome